Antibiotic overuse on Covid-19 patients in India prompts superbug concerns
NEW DELHI – India is likely to face a growing problem of antibiotic resistance in the next few years, fed by the abuse of powerful drugs in treating suspected bacterial infections in Covid-19 patients.
Patients in India, even those suffering mildly from Covid-19, have been administered strong antibiotics such as azithromycin and doxycycline while undergoing treatment despite clinical trials suggesting that these are not an effective treatment for the disease.
Please subscribe or log in to continue reading the full article.
Get unlimited access to all stories at $0.99/month
- Latest headlines and exclusive stories
- In-depth analyses and award-winning multimedia content
- Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*
*Terms and conditions apply.
Join ST’s Telegram channel here and get the latest breaking news delivered to you.
Source: Read Full Article